Mopidamol
Mopidamol (RA 233), a derivative of Dipyridamole (HY-B0312), is a phosphodiesterase inhibitor. Mopidamol can be used for non-small cell lung cancer (N-SCLC) research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 13665-88-8
- Formule: C19H31N7O4
- Masse moléculaire:421.49
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
Chemical Information
-
CAS No. 13665-88-8
-
Masse moléculaire 421.49
-
Formule C19H31N7O4
-
SMILES
OCCN(C1=NC=C2C(C(N3CCCCC3)=NC(N(CCO)CCO)=N2)=N1)CCO
-
Synonyms
RA 233
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Eliasson R, Bygdeman S. Effect of dipyridamole and two pyrimido-pyrimidine derivatives on the kinetics of human platelet aggregation and on platelet adhesiveness. Scand J Clin Lab Invest. 1969 Sep;24(2):145-51. [Content Brief]
[2]. Zacharski LR, et al. Effect of mopidamol on survival in carcinoma of the lung and colon: final report of Veterans Administration Cooperative Study No. 188. J Natl Cancer Inst. 1988 Mar 16;80(2):90-7. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Mopidamol Related Classifications
HY-106618 Related Classifications
Powered by Bioz